Article info

Download PDFPDF
Randomised controlled trial
Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

Authors

  1. Correspondence to : Dr Samir R Kapadia, Cleveland Clinic—Heart and Vascular Institute, Cleveland, OH 44195, USA; kapadis{at}ccf.org
View Full Text

Citation

Agarwal S, Kapadia SR
Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

Publication history

  • First published January 9, 2015.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.